The function of natural killer (NK) and myeloid cells depends on the balance of a number of activating and inhibitory receptors. Natural cytotoxicity receptors (NCR) are the major receptors responsible for NK cell-mediated lysis of tumor and viral-infected cells. Recent cloning of three NCRs, NKp46, NKp44, and NKp30, prompted studies by a number of investigators to elucidate their function as well as to identify their ligands. In the past few years, we have characterized the structure and function of several inhibitory as well as activating NK cell receptors. These include the crystal structures of CD94, KIR2DL2 and its complex with HLA-Cw3, NKG2D and its complex with ULBP3, NKp46 and TREM-1. Despite the progress made in understanding the function of NK receptors in the past few years, the ligands recognized by NCR remain unknown. Our effort of understanding the function of NCR has led a structural solution for NKp30. The structure revealed striking resemblence between NKp30 and CTLA-4 family receptors and enabled us to propose a potential ligand binding site. Heavy atom derivatization is routinely used in protein structure determination and is thus of critical importance in structural biology. In order to replace the current trial-and-error heavy atom derivative screening with a knowledge-based rational derivative selection method, we systematically examined the reactivity of more than forty heavy atom compounds over a wide range of buffer and pH on peptides which contained a single reactive amino acid residue. Met, Cys and His-containing peptides were derivatized against Hg, Au and Pt compounds while Tyr, Glu, Asp, Asn, and Gln-containing peptides were assessed against Pb compounds. A total of 1668 reactive conditions were examined using mass spectrometry and compiled into heavy atom reactivity tables. The results showed that heavy atom derivatization reactions are highly linked to buffer and pH with the most accommodating buffer being MES at pH 6. A group of 21 compounds were identified as most successful irrespective of ligand or buffer/pH conditions. To assess the applicability of the peptide heavy atom reactivity to proteins, lysozyme crystals were derivatized with a list of peptide reactive compounds that included both known and new compounds for lysozyme derivatization. The results showed highly consistent heavy atom reactivities between the peptide and lysozyme.

Project Start
Project End
Budget Start
Budget End
Support Year
18
Fiscal Year
2011
Total Cost
$1,110,575
Indirect Cost
City
State
Country
Zip Code
Spencer, Matthew; Max, Nathan; Ireland, Joanna et al. (2017) Over-expression of a human CD62L ecto-domain and a potential role of RNA pseudoknot structures in recombinant protein expression. Protein Expr Purif 140:65-73
Zou, Zhongcheng; Misasi, John; Sullivan, Nancy et al. (2017) Overexpression of Ebola virus envelope GP1 protein. Protein Expr Purif 135:45-53
Sim, Malcolm J W; Sun, Peter D (2017) HLA-F: A New Kid Licensed for Peptide Presentation. Immunity 46:972-974
Brown, Haley A; Roth, Gwynne; Holzapfel, Genevieve et al. (2015) Development of an improved mammalian overexpression method for human CD62L. Protein Expr Purif 105:8-13
Lu, Jinghua; Yu, Yadong; Zhu, Iowis et al. (2014) Structural mechanism of serum amyloid A-mediated inflammatory amyloidosis. Proc Natl Acad Sci U S A 111:5189-94
Wang, Ruipeng; Sun, Peter D (2014) Natural killer cell-mediated shedding of ULBP2. PLoS One 9:e91133
Abdi, Kaveh; Singh, Nevil J; Spooner, Eric et al. (2014) Free IL-12p40 monomer is a polyfunctional adaptor for generating novel IL-12-like heterodimers extracellularly. J Immunol 192:6028-36
Lu, Jinghua; Sun, Peter D (2014) A rapid and rational approach to generating isomorphous heavy-atom phasing derivatives. FEBS J 281:4021-8
Lu, Jinghua; Sun, Peter D (2012) The structure of the TLR5-flagellin complex: a new mode of pathogen detection, conserved receptor dimerization for signaling. Sci Signal 5:pe11
Joyce, M Gordon; Sun, Peter D (2011) The structural basis of ligand recognition by natural killer cell receptors. J Biomed Biotechnol 2011:203628

Showing the most recent 10 out of 16 publications